Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Efficacy of IL-6 antagonists in the treatment of COVID-19 patients: further randomized controlled trials are warranted.
Human Cell ( IF 4.3 ) Pub Date : 2021-09-15 , DOI: 10.1007/s13577-021-00616-x Aditya K Panda 1 , Sunali Padhi 1 , Abhijit Pati 1 , Tapan Kumar Singh Nayak 1
中文翻译：
IL-6 拮抗剂治疗 COVID-19 患者的疗效：需要进一步的随机对照试验。
更新日期：2021-09-15
Human Cell ( IF 4.3 ) Pub Date : 2021-09-15 , DOI: 10.1007/s13577-021-00616-x Aditya K Panda 1 , Sunali Padhi 1 , Abhijit Pati 1 , Tapan Kumar Singh Nayak 1
Affiliation
中文翻译：
IL-6 拮抗剂治疗 COVID-19 患者的疗效：需要进一步的随机对照试验。
京公网安备 11010802027423号